Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Genworth Financial Inc. (GNW) Stock Forecast & Price Prediction United States | NYSE | Financial Services | Insurance - Life
$6.93
-0.13 (-1.84%)10 Quality Stocks Worth Considering Now
Researching Genworth (GNW) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on GNW and similar high-potential opportunities.
Based on our analysis of 3 Wall Street analysts, GNW has a neutral consensus with a median price target of $8.50 (ranging from $8.50 to $8.50). The overall analyst rating is Buy (6.0/10). Currently trading at $6.93, the median forecast implies a 22.7% upside. This outlook is supported by 0 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Ryan Krueger at Keefe, Bruyette & Woods, projecting a 22.7% upside. Conversely, the most conservative target is provided by Ryan Krueger at Keefe, Bruyette & Woods, suggesting a 22.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for GNW.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 13, 2025 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $8.50 |
Apr 10, 2024 | Keefe, Bruyette & Woods | Ryan Krueger | Market Perform | Maintains | $7.00 |
Jun 11, 2018 | Wells Fargo | Sean Dargan | Market Perform | Maintains | $5.00 |
Nov 11, 2016 | Compass Point | Buy | Upgrade | $0.00 | |
Oct 5, 2016 | BTIG | Neutral | Downgrade | $0.00 | |
Oct 5, 2016 | BTIG Research | Neutral | Downgrade | $0.00 | |
Sep 23, 2016 | Goldman Sachs | Neutral | Maintains | $4.00 | |
Sep 19, 2016 | Compass Point | Neutral | Downgrade | $0.00 | |
Feb 9, 2016 | UBS | Sell | Maintains | $1.75 | |
Jan 22, 2016 | UBS | Sell | Maintains | $2.25 | |
Nov 17, 2015 | Goldman Sachs | Neutral | Initiates | $0.00 | |
Nov 4, 2015 | UBS | Sell | Downgrade | $0.00 | |
Oct 5, 2015 | JP Morgan | Neutral | Maintains | $8.00 | |
Sep 17, 2015 | Macquarie | Neutral | Maintains | $7.00 | |
Sep 2, 2015 | Keefe Bruyette & Woods | Maintains | $0.00 | ||
Sep 2, 2015 | Keefe, Bruyette & Woods | Maintains | $6.00 | ||
Aug 6, 2015 | Raymond James | Outperform | Downgrade | $0.00 | |
Aug 5, 2015 | Macquarie | Neutral | Upgrade | $0.00 | |
May 28, 2015 | Morgan Stanley | Equal-Weight | Upgrade | $0.00 | |
May 15, 2015 | Keefe Bruyette & Woods | Market Perform | Maintains | $0.00 |
The following stocks are similar to Genworth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Genworth Financial Inc. has a market capitalization of $2.87B with a P/E ratio of 13.1x. The company generates $7.22B in trailing twelve-month revenue with a 3.0% profit margin.
Revenue growth is -4.2% quarter-over-quarter, while maintaining an operating margin of +8.5% and return on equity of +3.8%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Provides insurance and investment solutions.
The company generates revenue primarily through its insurance products, including long-term care, mortgage, and life insurance. By underwriting these policies, Genworth protects both consumers and lenders, thus facilitating homeownership and addressing healthcare financial planning needs.
Founded in 1871 and based in Richmond, Virginia, Genworth has a significant presence in the housing and healthcare sectors. It plays a vital role in risk management and financial planning, contributing to consumer financial wellbeing and influencing trends in the insurance industry.
Financial Services
Insurance - Life
2,960
Mr. Thomas Joseph McInerney
United States
2004
Genworth Financial, Inc. (NYSE:GNW) will hold its Q1 2025 earnings conference call on May 1, 2025, at 10:00 AM ET, featuring key executives from the company.
Genworth Financial's upcoming Q1 2025 results call will provide insights into financial performance and strategic direction, impacting stock valuation and investor sentiment.
Genworth Financial (NYSE: GNW) reported strong Q1 2025 results, highlighting strategic execution in Enact, legacy insurance sustainability, and CareScout growth, indicating positive momentum for the year.
Genworth's strong quarterly results and strategic focus on growth indicate potential for increased profitability, which may boost investor confidence and stock performance.
Genworth Financial, Inc. (NYSE: GNW) will release its Q1 earnings on April 30, 2025, after market close, with a conference call on May 1, 2025, at 10:00 a.m. ET. Details will be available on their website.
Genworth Financial's upcoming earnings release and conference call could influence market perceptions and stock price, providing insights into the company's performance and future outlook.
Genworth has appointed Morris Taylor as Chief Information Officer, a move that may impact the company's strategic direction in technology.
Genworth's appointment of Morris Taylor as CIO may signal strategic shifts in technology and innovation, potentially impacting operational efficiency and market competitiveness.
Judy Benjamin, a certified health coach, will walk over 3,000 miles from San Diego to St. Augustine to promote healthy living, starting April 5. The journey will last five months.
Dr. Benjamin's cross-country walk highlights growing trends in health and wellness, potentially boosting investments in health-related industries and promoting alternative health solutions.
Genworth has elected Steven Van Wyk to its Board of Directors, as announced in a recent press release.
The election of Steven Van Wyk to Genworth's Board may indicate strategic shifts or enhancements in governance, potentially impacting company performance and shareholder value.
Based on our analysis of 3 Wall Street analysts, Genworth Financial Inc. (GNW) has a median price target of $8.50. The highest price target is $8.50 and the lowest is $8.50.
According to current analyst ratings, GNW has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $6.93. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict GNW stock could reach $8.50 in the next 12 months. This represents a 22.7% increase from the current price of $6.93. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue primarily through its insurance products, including long-term care, mortgage, and life insurance. By underwriting these policies, Genworth protects both consumers and lenders, thus facilitating homeownership and addressing healthcare financial planning needs.
The highest price target for GNW is $8.50 from Ryan Krueger at Keefe, Bruyette & Woods, which represents a 22.7% increase from the current price of $6.93.
The lowest price target for GNW is $8.50 from Ryan Krueger at Keefe, Bruyette & Woods, which represents a 22.7% increase from the current price of $6.93.
The overall analyst consensus for GNW is neutral. Out of 3 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $8.50.
Stock price projections, including those for Genworth Financial Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.